Cell Surface Markers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F- Product Image

New

Cell Surface Markers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

Report
184 Pages
March 2025
Region: Global
TechSci Research
ID: 5900238

The Cell Surface Markers Market was valued at USD 0.79 Billion in 2024, and is expected to reach USD 1.28 Billion by 2030, rising at a CAGR of 8.37%. The global cell surface markers market has been witnessing remarkable growth over the past few years, driven by advancements in cell-based research, diagnostics, and therapeutics. Cell surface markers, also known as cell surface antigens, are proteins or glycoproteins present on the surface of cells.

They play a crucial role in identifying and characterizing various cell types, which is essential for understanding cellular functions, disease mechanisms, and the development of targeted therapies. The cell surface markers market has been steadily expanding, thanks to the increasing demand for cell-based research in areas such as immunology, oncology, neuroscience, and regenerative medicine. These markers are pivotal for distinguishing between different cell populations, monitoring disease progression, and developing personalized treatment strategies.

Key Market Drivers

Rising Prevalence of Chronic Diseases is Driving the Global Cell Surface Markers Market

Chronic diseases have become a significant global health challenge, affecting millions and straining healthcare systems worldwide. Conditions such as cancer, diabetes, cardiovascular diseases, and autoimmune disorders are on the rise, contributing to increased healthcare expenditure and reduced quality of life. In 2019, chronic diseases accounted for 74% of deaths globally, up from 67% in 2010.

Specifically, diabetes has seen a dramatic increase, with over 800 million adults diagnosed worldwide, significantly higher than previous estimates. This surge underscores the urgent need for advanced diagnostic and therapeutic solutions. One such advancement is the utilization of cell surface markers, which play a pivotal role in diagnosing and treating these conditions. As the prevalence of chronic diseases continues to rise, the global cell surface markers market is experiencing robust growth.

Cell surface markers are widely used in the identification and classification of cancer cells. By analyzing the expression of specific markers on cancer cells, healthcare professionals can determine the type and stage of cancer, allowing for more personalized treatment strategies.

Key Market Challenges

Cost Constraints

Cost constraints pose a significant challenge in the global cell surface markers market, affecting both healthcare institutions and research organizations. The high cost of advanced diagnostic tools, such as flow cytometry and mass spectrometry, which rely on cell surface markers, limits accessibility for many laboratories and hospitals, particularly in developing regions. These technologies require substantial investments not only in procurement but also in maintenance, calibration, and specialized workforce training. The financial burden of acquiring and operating such sophisticated equipment creates a barrier for small- and medium-sized research facilities, restricting their ability to conduct large-scale studies or offer advanced diagnostic services.

Key Market Trends

Technological Advancements

In recent years, the healthcare and life sciences sectors have experienced remarkable technological progress that has transformed disease diagnosis, treatment, and research methodologies. A key beneficiary of these advancements is the global cell surface markers market, driven by the adoption of innovative techniques that enhance precision and efficiency in biomedical applications. Cell surface markers, also known as cluster of differentiation (CD) markers, are indispensable in cell biology, immunology, and cancer research.

Flow cytometry, a fundamental technique for analyzing cell populations, has evolved with the integration of high-dimensional instruments and artificial intelligence, significantly improving data accuracy and throughput. According to the U.S. National Institutes of Health, advancements in flow cytometry have bolstered diagnostic capabilities, enabling earlier detection and better management of various diseases. These technological improvements have expanded the use of cell surface markers in both clinical and research environments, fostering new avenues for scientific exploration and therapeutic innovation.

Single-cell analysis has further revolutionized our understanding of cellular heterogeneity and disease progression. Cutting-edge technologies such as single-cell RNA sequencing and mass cytometry (CyTOF) now permit detailed profiling of individual cells, with cell surface markers serving as critical identifiers in these analyses.

Key Market Players

Thermo Fisher Scientific Inc.
QIAGEN N.V.
Becton, Dickinson and Company.
Danaher Corporation
F. Hoffmann-La Roche AG
Bio-Rad Laboratories, Inc
Abcam plc
GenScript Biotech Corporation
BioLegend, Inc.
Merck KGaA

Report Scope:

In this report, the Global Cell Surface Markers Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cell Surface Markers Market, By Source:

Mice
Rats

Cell Surface Markers Market, By Product:

Antibodies
PCR Arrays
Others

Cell Surface Markers Market, By Cell type:

B Cell Surface Markers
Monocyte Cell Surface Markers
NK Cell Surface Markers
T Cell Surface Markers

Cell Surface Markers Market, By Application:

Clinical
Research

Cell Surface Markers Market, By Region:

North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia-Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Cell Surface Markers Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report.

Company Information

Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validations
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cell Surface Markers Market Outlook

5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Source (Mice, Rats)
5.2.2. By Product (Antibodies, PCR Arrays, Others)
5.2.3. By Cell Type ( B Cell Surface Markers, Monocyte Cell Surface Markers, NK Cell Surface Markers, T Cell Surface Markers)
5.2.4. By Application (Clinical, Research)
5.2.5. By Region
5.2.6. By Company (2024)
5.3. Market Map
5.3.1. By Source
5.3.2. By Product
5.3.3. By Cell Type
5.3.4. By Application
5.3.5. By Region

6. North America Cell Surface Markers Market Outlook

6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Source
6.2.2. By Product
6.2.3. By Cell Type
6.2.4. By Application
6.2.5. By Country
6.2.5.1. United States Cell Surface Markers Market Outlook
6.2.5.1.1. Market Size & Forecast
6.2.5.1.1.1. By Value
6.2.5.1.2. Market Share & Forecast
6.2.5.1.2.1. By Source
6.2.5.1.2.2. By Product
6.2.5.1.2.3. By Cell Type
6.2.5.1.2.4. By Application
6.2.5.1.2.5. By End Use
6.2.5.2. Canada Cell Surface Markers Market Outlook
6.2.5.2.1. Market Size & Forecast
6.2.5.2.1.1. By Value
6.2.5.2.2. Market Share & Forecast
6.2.5.2.2.1. By Source
6.2.5.2.2.2. By Product
6.2.5.2.2.3. By Cell Type
6.2.5.2.2.4. By Application
6.2.5.2.2.5. By End Use
6.2.5.3. Mexico Cell Surface Markers Market Outlook
6.2.5.3.1. Market Size & Forecast
6.2.5.3.1.1. By Value
6.2.5.3.2. Market Share & Forecast
6.2.5.3.2.1. By Source
6.2.5.3.2.2. By Product
6.2.5.3.2.3. By Cell Type
6.2.5.3.2.4. By Application
6.2.5.3.2.5. By End Use

7. Europe Cell Surface Markers Market Outlook

7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Source
7.2.2. By Product
7.2.3. By Cell Type
7.2.4. By Application
7.2.5. By End Use
7.2.6. By Country
7.2.6.1. France Cell Surface Markers Market Outlook
7.2.6.1.1. Market Size & Forecast
7.2.6.1.1.1. By Value
7.2.6.1.2. Market Share & Forecast
7.2.6.1.2.1. By Source
7.2.6.1.2.2. By Product
7.2.6.1.2.3. By Cell Type
7.2.6.1.2.4. By Application
7.2.6.1.2.5. By End Use
7.2.6.2. Germany Cell Surface Markers Market Outlook
7.2.6.2.1. Market Size & Forecast
7.2.6.2.1.1. By Value
7.2.6.2.2. Market Share & Forecast
7.2.6.2.2.1. By Source
7.2.6.2.2.2. By Product
7.2.6.2.2.3. By Cell Type
7.2.6.2.2.4. By Application
7.2.6.2.2.5. By End Use
7.2.6.3. United Kingdom Cell Surface Markers Market Outlook
7.2.6.3.1. Market Size & Forecast
7.2.6.3.1.1. By Value
7.2.6.3.2. Market Share & Forecast
7.2.6.3.2.1. By Source
7.2.6.3.2.2. By Product
7.2.6.3.2.3. By Cell Type
7.2.6.3.2.4. By Application
7.2.6.3.2.5. By End Use
7.2.6.4. Italy Cell Surface Markers Market Outlook
7.2.6.4.1. Market Size & Forecast
7.2.6.4.1.1. By Value
7.2.6.4.2. Market Share & Forecast
7.2.6.4.2.1. By Source
7.2.6.4.2.2. By Product
7.2.6.4.2.3. By Cell Type
7.2.6.4.2.4. By Application
7.2.6.4.2.5. By End Use
7.2.6.5. Spain Cell Surface Markers Market Outlook
7.2.6.5.1. Market Size & Forecast
7.2.6.5.1.1. By Value
7.2.6.5.2. Market Share & Forecast
7.2.6.5.2.1. By Source
7.2.6.5.2.2. By Product
7.2.6.5.2.3. By Cell Type
7.2.6.5.2.4. By Application
7.2.6.5.2.5. By End Use

8. Asia Pacific Cell Surface Markers Market Outlook

8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Source
8.2.2. By Product
8.2.3. By Cell Type
8.2.4. By Application
8.2.5. By End Use
8.2.6. By Country
8.2.6.1. China Cell Surface Markers Market Outlook
8.2.6.1.1. Market Size & Forecast
8.2.6.1.1.1. By Value
8.2.6.1.2. Market Share & Forecast
8.2.6.1.2.1. By Source
8.2.6.1.2.2. By Product
8.2.6.1.2.3. By Cell Type
8.2.6.1.2.4. By Application
8.2.6.1.2.5. By End Use
8.2.6.2. India Cell Surface Markers Market Outlook
8.2.6.2.1. Market Size & Forecast
8.2.6.2.1.1. By Value
8.2.6.2.2. Market Share & Forecast
8.2.6.2.2.1. By Source
8.2.6.2.2.2. By Product
8.2.6.2.2.3. By Cell Type
8.2.6.2.2.4. By Application
8.2.6.2.2.5. By End Use
8.2.6.3. South Korea Cell Surface Markers Market Outlook
8.2.6.3.1. Market Size & Forecast
8.2.6.3.1.1. By Value
8.2.6.3.2. Market Share & Forecast
8.2.6.3.2.1. By Product
8.2.6.3.2.2. By Source
8.2.6.3.2.3. By Product
8.2.6.3.2.4. By Cell Type
8.2.6.3.2.5. By Application
8.2.6.3.2.6. By End Use
8.2.6.4. Japan Cell Surface Markers Market Outlook
8.2.6.4.1. Market Size & Forecast
8.2.6.4.1.1. By Value
8.2.6.4.2. Market Share & Forecast
8.2.6.4.2.1. By Source
8.2.6.4.2.2. By Product
8.2.6.4.2.3. By Cell Type
8.2.6.4.2.4. By Application
8.2.6.4.2.5. By End Use
8.2.6.5. Australia Cell Surface Markers Market Outlook
8.2.6.5.1. Market Size & Forecast
8.2.6.5.1.1. By Value
8.2.6.5.2. Market Share & Forecast
8.2.6.5.2.1. By Source
8.2.6.5.2.2. By Product
8.2.6.5.2.3. By Cell Type
8.2.6.5.2.4. By Application
8.2.6.5.2.5. By End Use

9. South America Cell Surface Markers Market Outlook

9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Source
9.2.2. By Product
9.2.3. By Cell Type
9.2.4. By Application
9.2.5. By End Use
9.2.6. By Country
9.2.6.1. Brazil Cell Surface Markers Market Outlook
9.2.6.1.1. Market Size & Forecast
9.2.6.1.1.1. By Value
9.2.6.1.2. Market Share & Forecast
9.2.6.1.2.1. By Product
9.2.6.1.2.2. By Indication
9.2.6.1.2.3. By Source
9.2.6.1.2.4. By End Use
9.2.6.2. Argentina Cell Surface Markers Market Outlook
9.2.6.2.1. Market Size & Forecast
9.2.6.2.1.1. By Value
9.2.6.2.2. Market Share & Forecast
9.2.6.2.2.1. By Source
9.2.6.2.2.2. By Product
9.2.6.2.2.3. By Cell Type
9.2.6.2.2.4. By Application
9.2.6.2.2.5. By End Use
9.2.6.3. Colombia Cell Surface Markers Market Outlook
9.2.6.3.1. Market Size & Forecast
9.2.6.3.1.1. By Value
9.2.6.3.2. Market Share & Forecast
9.2.6.3.2.1. By Source
9.2.6.3.2.2. By Product
9.2.6.3.2.3. By Cell Type
9.2.6.3.2.4. By Application
9.2.6.3.2.5. By End Use

10. Middle East & Africa Cell Surface Markers Market Outlook

10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Source
10.2.2. By Product
10.2.3. By Cell Type
10.2.4. By Application
10.2.5. By End Use
10.2.6. By Country
10.2.6.1. South Africa Cell Surface Markers Market Outlook
10.2.6.1.1. Market Size & Forecast
10.2.6.1.1.1. By Value
10.2.6.1.2. Market Share & Forecast
10.2.6.1.2.1. By Source
10.2.6.1.2.2. By Product
10.2.6.1.2.3. By Cell Type
10.2.6.1.2.4. By Application
10.2.6.1.2.5. By End Use
10.2.6.2. Saudi Arabia Cell Surface Markers Market Outlook
10.2.6.2.1. Market Size & Forecast
10.2.6.2.1.1. By Value
10.2.6.2.2. Market Share & Forecast
10.2.6.2.2.1. By Source
10.2.6.2.2.2. By Product
10.2.6.2.2.3. By Cell Type
10.2.6.2.2.4. By Application
10.2.6.2.2.5. By End Use
10.2.6.3. UAE Cell Surface Markers Market Outlook
10.2.6.3.1. Market Size & Forecast
10.2.6.3.1.1. By Value
10.2.6.3.2. Market Share & Forecast
10.2.6.3.2.1. By Source
10.2.6.3.2.2. By Product
10.2.6.3.2.3. By Cell Type
10.2.6.3.2.4. By Application
10.2.6.3.2.5. By End Use

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches

13. Competitive Landscape

13.1. Thermo Fisher Scientific Inc.
13.1.1. Business Overview
13.1.2. Application Offerings
13.1.3. Recent Developments
13.1.4. Key Personnel
13.1.5. SWOT Analysis
13.2. QIAGEN N.V.
13.3. Becton, Dickinson and Company.
13.4. Danaher Corporation
13.5. F. Hoffmann-La Roche AG
13.6. Bio-Rad Laboratories, Inc
13.7. Abcam plc
13.8. GenScript Biotech Corporation
13.9. BioLegend, Inc.
13.10. Merck KGaA

14. Strategic Recommendations15. About the Publisher & Disclaimer

Companies Mentioned

Thermo Fisher Scientific Inc.
QIAGEN N.V.
Becton, Dickinson and Company.
Danaher Corporation
F. Hoffmann-La Roche AG
Bio-Rad Laboratories, Inc
Abcam plc
GenScript Biotech Corporation
BioLegend, Inc.
Merck KGaA

Table Information

Report Attribute	Details
No. of Pages	184
Published	March 2025
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 0.79 Billion
Forecasted Market Value ( USD ) by 2030	$ 1.28 Billion
Compound Annual Growth Rate	8.3%
Regions Covered	Global
No. of Companies Mentioned	10

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€4095EUR$4,500USD£3,511GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€5006EUR$5,500USD£4,291GBP